Our Team
The team at the Mary Tyler Moore Vision Initiative seeks to preserve and restore vision in people with diabetes.
Leadership
S. Robert Levine, MD
Concept Creator and Chair
Eric Carlson
Co-Directors Media and Cause Marketing
Susan Carlson
Co-Directors Media and Cause Marketing
Patrice Fort, PhD, MS
Director, MTM Vision Initiative Biorepository and Resource Center
Tom Gardner, MD, MS
Scientific Co-Director
Dorene Markel, MS, MHSA
Managing Director
Carol Oxenreiter, BS
Chair, Lay Advisory Board
Jennifer Sun, MD, MPH
Scientific Co-Director
Red Maxwell
Chair, Marketing and Communications Advisory Committee
Mark Atkinson, PhD
Interim Chair, External Scientific Advisory Board
Team Members
Corey Porter, PhD
Technical Manager, Biorepository and Resource Center
Kelli Ramos, BS
Project Manager Biorepository and Resource Center
Terry Sims
Executive Assistant to Dr. Levine
Shelby Unsworth, PhD
Associate Director for Business Development, University of Michigan Medical School
Carmen Yu
Research Lab Specialist Senior, Biorepository and Resource Center
Media and Fund Development Advisors
Tom Brobson
JDRF Volunteer; Former, JDRF National Director, Research Investment Opportunities
Brian Gott
Chief Innovation Officer & Head of Industry Relations for the Entertainment Industry Foundation
Nicole Sexton
President and CEO, Entertainment Industry Foundation
Lisa Fishbone Wallack, JD
Volunteer Leader, JDRF
Lay Advisory Committee
Carol Oxenreiter (Chair)
Tom Chapman, MBA
CIO Teewinot Partners, living with T1D for decades
Chris German, PhD
Senior Scientist, Myriad Genetics, living with T1D for decades
Judy Hunt, MBA
Parent of daughter living with T1D for >30 years, T1D research advocate
Monica Oxenreiter, MBA, MPP
VP of Content at Close Concerns, living with T1D for over 30 years
Sandra Puczynski, PhD
JDRF Director Emeritus; former JDRF Research Chair and IBOD Member, parent of daughter with T1D for over 30 years
External Scientific Advisory Board
Mark Atkinson, PhD
Univ. of Florida, Director, University of Florida Diabetes Institute; Director, nPOD and CaRe-T1D
Sally Baxter, MD
UCSD Shiley Eye Institute, Division Chief for Ophthalmology Informatics and Data Science (anticipated joining July, 2024)
Dolly Chang, MD, MPH, PhD
Genentech, Sr. Medical Director, Research and Early Development
Sanjoy Dutta, PhD
JDRF, Chief Scientific Officer
Stephen McLeod, MD
America Academy of Ophthalmology, Chief Executive Officer
Tunde Peto, MD, PhD
Queen’s University Belfast (QUB), Professor of Clinical Ophthalmology
Marlon Pragnell, PhD
ADA, Vice President of Research & Science
Christopher Rhodes, PhD
AstraZeneca, Chief Scientist/Vice President, Cardiovascular, Renal & Metabolic Disease, Biopharmaceuticals R & D
Jose Sahel, MD, PhD
Univ. of Pittsburgh School of Medicine, Chair Ophthalmology
Marie Schiller
Interim CEO, The Diabetes Link; former VP Drug Development/Device R&D Innovation, Eli Lilly and Company
Don Zack, MD, PhD
Co-Director, Johns Hopkins Center for Stem Cells and Ocular Regenerative Medicine
